Immuneering Corp Quarterly Depreciation in USD from Q2 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Immuneering Corp quarterly/annual Depreciation history and growth rate from Q2 2020 to Q1 2024.
  • Immuneering Corp Depreciation for the quarter ending March 31, 2024 was $90.2K, a 17.9% increase year-over-year.
  • Immuneering Corp annual Depreciation for 2023 was $323K, a 30.6% increase from 2022.
  • Immuneering Corp annual Depreciation for 2022 was $247K, a 444% increase from 2021.
  • Immuneering Corp annual Depreciation for 2021 was $45.5K, a 86.9% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $90.2K +$13.7K +17.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q1 2023 $276K $76.5K +$28.8K +60.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $247K $76.9K +$62K +419% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-01
Q3 2022 $185K $68.1K +$56.1K +468% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $129K $54.6K +$44.8K +456% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $84.3K $47.7K +$38.8K +438% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $45.5K $14.8K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q3 2021 $12K +$6.32K +112% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $9.81K +$3.89K +65.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $8.87K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 $5.66K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $5.92K Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.